Pathological antibody-mediated rejection in pediatric heart transplant recipients: Immunologic risk factors, hemodynamic significance, and outcomes.

MLA

Hollander, Seth A., et al. “Pathological Antibody-Mediated Rejection in Pediatric Heart Transplant Recipients: Immunologic Risk Factors, Hemodynamic Significance, and Outcomes.” Pediatric Transplantation, vol. 22, no. 5, Aug. 2018, p. e13197. EBSCOhost, https://doi.org/10.1111/petr.13197.

APA

Hollander, S. A., Peng, D. M., Mills, M., Berry, G. J., Fedrigo, M., McElhinney, D. B., Almond, C. S., & Rosenthal, D. N. (2018). Pathological antibody-mediated rejection in pediatric heart transplant recipients: Immunologic risk factors, hemodynamic significance, and outcomes. Pediatric Transplantation, 22(5), e13197. https://doi.org/10.1111/petr.13197

Chicago

Hollander, Seth A, David M Peng, Marcos Mills, Gerald J Berry, Marny Fedrigo, Doff B McElhinney, Christopher S Almond, and David N Rosenthal. 2018. “Pathological Antibody-Mediated Rejection in Pediatric Heart Transplant Recipients: Immunologic Risk Factors, Hemodynamic Significance, and Outcomes.” Pediatric Transplantation 22 (5): e13197. doi:10.1111/petr.13197.